Collaborating with research leaders and advocates, we’re on a mission to transform outcomes, inspire hope, and redefine cancer care. At NEXS Biomedica, we are driven by a passion for innovation in healthcare. As a pharmaceutical startup, our mission is to develop advanced therapies that address some of the most pressing medical needs, with a current focus on metabolic health and weight management. Our dedicated team of researchers, clinicians, and industry experts leverage cutting-edge science and technology to bring new treatments to market that can transform patient care. We are committed to improving the quality of life through our innovative approach to drug development, combining clinical expertise with scientific rigor to create safe, effective, and accessible pharmaceutical solutions. NES Biomedica's current projects include a novel weight loss drug that utilizes a proprietary formulation of Symlin and Topiramate in a slow-release injectable form, aimed at tackling the growing global challenge of obesity. With a focus on safety, efficacy, and patient outcomes, we strive to lead the way in delivering groundbreaking therapies that make a lasting impact. At NES Biomedica, our vision is clear: to bring transformative healthcare solutions to patients worldwide, helping them achieve better health and a brighter future.
